Tivortin aspartate has an antihypoxic, protective, antioxidant, detoxifying, membrane-stabilizing effect. It plays an important role in the processes of ammonia neutralization and stimulation of its removal from the body, strengthens the detoxification function of the liver. Has a hepatoprotective effect, has a positive effect on energy supply processes in hepatocytes.
As a donor of nitric oxide, Tivortin aspartate participates in the processes of energy supply of the body, reduces the activation and adhesion of leukocytes and platelets to the endothelium of vessels, preventing the formation and development of atherosclerotic plaques, is included in the processes of fibrinogenolysis, spermatogenesis.
The drug exhibits a moderate anabolic effect, stimulates the activity of the thymus gland, promotes the synthesis of insulin and regulates the glucose content in the blood during physical activity, helps to correct the acid-alkaline balance.
Indication
It is used in complex therapy of atherosclerosis of heart and brain vessels, arterial hypertension, atherosclerosis of peripheral vessels; diabetic angiopathy; chronic heart failure, hypercholesterolemia; chronic obstructive lung diseases, pulmonary hypertension; asthenic states.
Contraindication
Hypersensitivity, severe renal dysfunction. Myocardial infarction (including history).
Method of application and dosage
Use inside to take during meals. Adults with atherosclerosis of the vessels of the heart and brain, atherosclerosis of peripheral vessels, diabetic angiopathy – 5 ml (1 measuring spoon – 1 g of the drug) 3-8 times a day. With hypercholesterolemia, arterial hypertension – 5 ml 3-6 times a day. With chronic obstructive lung diseases, pulmonary hypertension – 5 ml 3-6 times a day. In asthenic conditions – 5 ml 4-8 times a day. The maximum daily dose is 8 g. The duration of the course of treatment is 8-15 days, if necessary, the course of treatment is repeated.
Children.
Not applicable to patients under 18 years of age.
Overdose
Symptoms: reactions of increased sensitivity, hypoglycemic state.
Treatment. In the presence of these phenomena, it is necessary to stop taking the drug. Gastric lavage, administration of sorbents is indicated. There is no antidote.
Composition
active substance L-arginine aspartate;
1 ml of L-arginine aspartate 200 mg
auxiliary substances: sorbitol (E 420), sodium saccharin (E 954), methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), food flavoring “Caramel”, water for injections.
Storage conditions
Store in the original packaging at a temperature not higher than 25 °C. Keep out of the reach of children. Do not freeze.
Shelf life – 2 years.
The shelf life after opening the bottle is 14 days.
Reviews
There are no reviews yet.